emerging biotech companies with products in phase 2 or phase 3

primary.main

newThemeBody1

1,200

newThemeBody11

molecules approved by FDA in next 5 years to come from emerging biotechs

of recent product launches underperformed sales forecasts

indegeneWhite.main

Let’s partner for #FutureReadyHealthcare

newThemeh2

Develop, launch and market your product with an experienced partner

Development and Co-commercialization

newThemeh1

Innovate at the commercial end of the value chain

newThemeBody5

Digital transformation of clinical trials

Enhancing brand launch with patient insights and RWD

Harnessing the power of data analytics

Regulatory Intelligence - Key to successful submissions

The metaverse now: Top 3 immediate use cases

indegeneBlack.main

Insights to build #FutureReadyHealthcare

Medical innovation should extend to commercialization

and require a fully-staffed internal team or capital-intensive consultants

Costly

newThemeh3

to develop necessary infrastructure and adopt cutting-edge technology

Challenging

as large company partnerships reduce revenue share and autonomy

Restrictive

Existing development and commercialization models are  

Raised by an emerging biotech company with the support of our commercialization partnership for two products

3rem

$25 million

Secured by an emerging biotech company based on investor confidence with our ability to set up manufacturing and launch

$30 million

Raised by a single-product biotech company by having our operational and commercialization support to complete a phase 3 clinical trial and bring to market

$50 million

Emerging biotech leaders leverage Indegene’s reputation to secure funding

Adopt a partnership model with custom-tailored, integrated solutions that builds revenue while growing your brand, and allows for autonomy of profit

Align costs with revenue growth

newThemeh4

Benefit from a seamless and flexible partnership, purpose-built with institutional expertise across the development to commercialization value chain

Partner with a single expert across the lifecycle

Utilize cutting edge artificial intelligence and IP-driven digital marketing tools to reach targeted stakeholders and drive overall prescriptions

Adopt technology to accelerate path to prescription

Reimagine the partnership with commercialization specialists

We apply expertise and technology across the medical affairs lifecycle from research and planning to content development, regulatory submissions and health authority query management to ensure seamless compliance in a complex and evolving landscape. Our AI-driven pharmacovigilance platform improves the effectiveness of monitoring, analysis, reporting, and risk mitigation of adverse event signals across the product lifecycle while ensuring continuous regulatory compliance. We improve overall customer engagement with modern medical affairs operations.

Medical Operations

We help you scale commercial operations with adaptable, automated modular content, and comprehensive omnichannel campaign management to create outstanding customer experiences. Our proficiency, coupled with technology-driven review and approval operations ensure accurate, impactful, and compliant external communications. With deep data literacy and an analytical knowledge of therapeutics, we maximize the value of your data, translate insights into actions, and drive business outcomes. Through our partnerships and platforms, we enhance your patient support programs from identification and onboarding to engagement and adherence. Our understanding of patients, payers and HCPs' value perceptions help broaden and deepen market access with data-driven pricing and reimbursement strategies..

Commercial Operations

We leverage data and analytics through a digital-first approach to enhance your brand planning for maximum impact. With deep insights into healthcare provider behavior, we develop a hyper segmentation model to identify HCPs with the greatest potential to engage digitally and drive prescription behavior. In turn, we use data to create relevant, personalized and scalable content to effectively meet these physicians where they are. We continually monitor content and channel effectiveness to maximize the returns from your marketing investment.

Omnichannel Activation

We generate insights from real-world data (RWD) and molecular data to detect gaps in the R&D lifecycle, support biomarker development and improve clinical trial designs. Our targeted digital marketing capabilities enable us to identify patients, conduct efficient primary and secondary screening, and pair them with clinical trial sites, accelerating study startup. We coordinate contract management, budgeting and payment, data standardization and aggregation, risk-based quality management (RBQM), study-specific portals and patient engagement support. Expert data managers set up and monitor trials ensuring reliable clinical data through protocol-based collection mechanisms.